X-ray generator developer Creos International of Fife, Scotland, has been encountering financial problems of late. The company last month requested that its shares be suspended from trading on the Alternative Investment Market of the U.K. while it
X-ray generator developer Creos International of Fife, Scotland, has been encountering financial problems of late. The company last month requested that its shares be suspended from trading on the Alternative Investment Market of the U.K. while it considers its financial position. The company has closed its subsidiary, Creos Limited, and is seeking the appointment of a provisional liquidator.
The companys compact x-ray generator technology will live on, however. In December, Creos Limiteds U.S. subsidiary, Creos Inc., sold its business and assets to Colorado businessman Peter Cooper, who founded a new, private company, Creos Technologies of Englewood, CO. Creos Technologies employs 33 people and manufactures the high-powered, high-frequency x-ray generators initially developed by Creos International (SCAN 7/13/94). Creos International holds a residual interest in the new company.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.
2 Commerce Drive
Cranbury, NJ 08512